Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation

Meghan G. Hill, Mehtab K. Sekhon, Kathryn L Reed, Caroline F. Anderson, Nydia D. Borjon, Jil C Tardiff, Brent J. Barber

Research output: Contribution to journalArticle

Abstract

There is no clear consensus on optimal management of fetuses affected by familial hypertrophic cardiomyopathy (HCM). Intrauterine treatment of the condition has not been attempted in any standardized fashion. We report the case of a fetus treated by maternal propranolol during the third trimester after septal hypertrophy and diastolic dysfunction was diagnosed on fetal echocardiogram. The pregnancy went successfully to term, and fetal septal hypertrophy was noted to improve prior to delivery.

Original languageEnglish (US)
Pages (from-to)1774-1777
Number of pages4
JournalPediatric Cardiology
Volume36
Issue number8
DOIs
StatePublished - Dec 1 2015

Fingerprint

Familial Hypertrophic Cardiomyopathy
Hypertrophy
Fetus
Mutation
Third Pregnancy Trimester
Propranolol
Mothers
Pregnancy

Keywords

  • Beta myosin mutation
  • Fetal echocardiography
  • Fetal hypertrophic cardiomyopathy
  • Propranolol

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation. / Hill, Meghan G.; Sekhon, Mehtab K.; Reed, Kathryn L; Anderson, Caroline F.; Borjon, Nydia D.; Tardiff, Jil C; Barber, Brent J.

In: Pediatric Cardiology, Vol. 36, No. 8, 01.12.2015, p. 1774-1777.

Research output: Contribution to journalArticle

Hill, Meghan G. ; Sekhon, Mehtab K. ; Reed, Kathryn L ; Anderson, Caroline F. ; Borjon, Nydia D. ; Tardiff, Jil C ; Barber, Brent J. / Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation. In: Pediatric Cardiology. 2015 ; Vol. 36, No. 8. pp. 1774-1777.
@article{77e05e9479a144e381d3a3849d622ac7,
title = "Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation",
abstract = "There is no clear consensus on optimal management of fetuses affected by familial hypertrophic cardiomyopathy (HCM). Intrauterine treatment of the condition has not been attempted in any standardized fashion. We report the case of a fetus treated by maternal propranolol during the third trimester after septal hypertrophy and diastolic dysfunction was diagnosed on fetal echocardiogram. The pregnancy went successfully to term, and fetal septal hypertrophy was noted to improve prior to delivery.",
keywords = "Beta myosin mutation, Fetal echocardiography, Fetal hypertrophic cardiomyopathy, Propranolol",
author = "Hill, {Meghan G.} and Sekhon, {Mehtab K.} and Reed, {Kathryn L} and Anderson, {Caroline F.} and Borjon, {Nydia D.} and Tardiff, {Jil C} and Barber, {Brent J.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s00246-015-1250-1",
language = "English (US)",
volume = "36",
pages = "1774--1777",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation

AU - Hill, Meghan G.

AU - Sekhon, Mehtab K.

AU - Reed, Kathryn L

AU - Anderson, Caroline F.

AU - Borjon, Nydia D.

AU - Tardiff, Jil C

AU - Barber, Brent J.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - There is no clear consensus on optimal management of fetuses affected by familial hypertrophic cardiomyopathy (HCM). Intrauterine treatment of the condition has not been attempted in any standardized fashion. We report the case of a fetus treated by maternal propranolol during the third trimester after septal hypertrophy and diastolic dysfunction was diagnosed on fetal echocardiogram. The pregnancy went successfully to term, and fetal septal hypertrophy was noted to improve prior to delivery.

AB - There is no clear consensus on optimal management of fetuses affected by familial hypertrophic cardiomyopathy (HCM). Intrauterine treatment of the condition has not been attempted in any standardized fashion. We report the case of a fetus treated by maternal propranolol during the third trimester after septal hypertrophy and diastolic dysfunction was diagnosed on fetal echocardiogram. The pregnancy went successfully to term, and fetal septal hypertrophy was noted to improve prior to delivery.

KW - Beta myosin mutation

KW - Fetal echocardiography

KW - Fetal hypertrophic cardiomyopathy

KW - Propranolol

UR - http://www.scopus.com/inward/record.url?scp=84947866803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947866803&partnerID=8YFLogxK

U2 - 10.1007/s00246-015-1250-1

DO - 10.1007/s00246-015-1250-1

M3 - Article

C2 - 26337809

AN - SCOPUS:84947866803

VL - 36

SP - 1774

EP - 1777

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 8

ER -